Zhengye Biotechnology Holding Limited
Health
Performance
10.0
Risk
Sell
Buy
Curious about the Scores? Learn more.

Zhengye Biotechnology Holding Limited stock rating and score history

All changes in ratings, performance and outlook tracked over time.

22.07.2026
Rock bottom. The fall’s complete, stability nowhere to be found.
22.07.2026
Momentum tanked. Clearly underperforming.
01.07.2026
Danger zone. Balance sheet’s flashing red across the board.
02.02.2026
Red alert. Risk levels out of control.
ZYBT
Zhengye Biotechnology Holding Limited
1.38
-51.58%
10.0
Sell
Buy
Zhengye Biotechnology Holding Limited

Zhengye Biotechnology Holding Limited stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Zhengye Biotechnology Holding Limited do? Business model and key facts

Get the full picture of Zhengye Biotechnology Holding Limited: what it builds, where it operates, and how it makes money.

Zhengye Biotechnology Holding Limited Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 269

Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.

shop
Company facts
Songlin Song
CEO
269
Employees worldwide
shop
Performance
-74.82%
Last 12 months
shop
Growth
$116.36M
Revenue year
$-82,968,000
Net income
shop
Valuation
$33.08M
Market Cap
-5.74
Price/Earnings Ratio

Stocks related to Zhengye Biotechnology Holding Limited

Selected based on industry alignment and relative market positioning.

OGI
Organigram Global Inc.
0.92
-2.91%
10.0
Sell
Buy
Organigram Global Inc.
LFCR
Lifecore Biomedical, Inc.
4.58
-1.29%
9.0
Sell
Buy
Lifecore Biomedical, Inc.
EMBC
Embecta Corp.
3.25
-3.56%
8.9
Sell
Buy
Embecta Corp.

Events and news impacting Zhengye Biotechnology Holding Limited stock

Earnings, coporate decisions and industry developments that can affect the share price.

Zhengye Biotechnology Holding Limited fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.